News
SENATOR Newsletter April 2017
SENATOR Consortium is delighted to announce that 800 patients have been randomized to phase 2 of the trial since commencement. Congratulations to all sites on their hard work and dedication in recruiting over the last few months!...[more]
Dr. Isabel Lozano about ONTOP and SENATOR in Hospital Cruz Roja in Madrid
Dr. Isabel Lozano from SENATOR Madrid clinical center has talked on 8th March 2017 in Hospital Cruz Roja (Madrid) about Definition of Optimal Evidence-Based Non-drug Therapies in Older People (ONTOP). She has presented ...[more]
600th randomised patient
SENATOR Consortium is delighted to announce that the project reached its 600th randomised patient last Thursday 23rd February 2017, hitting the one-third mark towards the target of 1800 patients to be recruited to SENATOR. This...[more]
Invited Lecture Prof. O´Mahony
On January 27th, 2017 Prof. Denis O´Mahony, coordinator of SENATOR, was invited to give a lecture to the annual scientific meeting Prescribing & Research In Medicines Management (UK & Ireland) in London. The title of the...[more]
SENATOR Newsletter December 2016
SENATOR Group is closed to hit the Christmas recruitment target of 400 patients. Congratulations to all clinical sites and keep enrolling! To get more information please read the whole December Newsletter here.[more]
SENATOR at The Icelandic Society of Internal Medicine Congress 2016
SENATOR team in Iceland did introduce SENATOR at The Icelandic Society of Internal Medicine Congress 2016 at the conference venue Harpan, Reykjavík. Congratulations to Aðalsteinn Guðmundsson, Ástrós Sverrisdóttir, Pétur...[more]
Special editorial on the SENATOR project in Therapeutic Advances in Drug Safety
The scientists involved in SENATOR project published a special editorial on ´The SENATOR project: developing and trialling a novel software engine to optimizemedications and nonpharmacological therapy in older people with...[more]
